probiome Sign in
← Conditions Heart, blood and vesselsSkin Genus-level

Kawasaki disease

Compared within 1 study that had both: 60 people with Kawasaki disease and 30 healthy people. No genera less common in people with Kawasaki disease, and none more common.

A difference is an association: it doesn’t mean these genera cause, prevent or treat Kawasaki disease. GMrepo reports this group at the genus level only, so these are genera, not species.

Searching opens both lists and shows only matching rows.

Less common in Kawasaki disease · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

More common in Kawasaki disease · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in China.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 44 genera

Compared within studies that had both, but not listed above.

No meaningful difference · 44
PubMed · human studies and reviews first

Recent research

All research on it
  1. Frontiers in immunology · 2026
    Multi-omics analyses reveal significant differences in the gut microbiota and metabolites in children with Kawasaki disease in Northwest China.
    PubMed ↗
  2. Observational Virulence · 2025
    Eggerthella lenta down regulated flavone and flavonol biosynthesis promoted Kawasaki disease.
    PubMed ↗
  3. Animal study Circulation research · 2025
    Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice.
    PubMed ↗
  4. Observational Frontiers in immunology · 2024
    Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children.
    PubMed ↗
  5. Frontiers in immunology · 2023
    Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 5 linked papers, last 10 years